Your browser doesn't support javascript.
loading
Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes.
Int J Cancer ; 132(11): 2557-66, 2013 Jun 01.
Article in En | MEDLINE | ID: mdl-23151995

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Genetic Therapy / Cancer Vaccines / Melanoma / Antigens, Neoplasm / Neoplasm Proteins Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2013 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Genetic Therapy / Cancer Vaccines / Melanoma / Antigens, Neoplasm / Neoplasm Proteins Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2013 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos